[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354993-105":59,"doc-detail-354993-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glutamine-transporter-slc1a5-inhibits-autophagy-mediated-cd276-degradation-to-promote-esophageal-cancer-progression","Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression","","Background: CD276/B7-H3 is an immune checkpoint molecule frequently overexpressed in cancers, and its upregulation mechanisms remain unclear. This study examines how glutamine metabolism regulates CD276 protein stability and esophageal squamous cell carcinoma (ESCC) progression. Methods: CD276 and SLC1A5 were assessed in 90 clinical ESCC tissues and TCGA/GEO datasets, with functional assays in ESCC cell lines and autophagy quantified by immunofluorescence and western blot, plus mitochondrial ROS measurements by flow cytometry. In vivo, the SLC1A5 inhibitor V9302 was tested using NOD/SCID mice bearing KYSE150 xenografts. Results: SLC1A5 stabilized CD276 by suppressing ROS-dependent autophagic degradation, and targeting glutamine metabolism reduced CD276-driven ESCC growth. Conclusion: SLC1A5-mediated ROS-autophagy signaling promotes ESCC progression, suggesting glutamine-metabolism targeting to enhance CD276 degradation as a therapeutic strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glutamine-transporter-slc1a5-inhibits-autophagy-mediated-cd276-degradation-to-promote-esophageal-cancer-progression/354993/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glutamine-transporter-slc1a5-inhibits-autophagy-mediated-cd276-degradation-to-promote-esophageal-cancer-progression/354993.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CD276/B7-H3 play in esophageal squamous cell carcinoma?","Question",{"text":112,"@type":113},"CD276/B7-H3 is an immune checkpoint molecule often overexpressed in cancers. In the study, CD276 overexpression enhanced ESCC cell proliferation and migration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SLC1A5 affect CD276 levels in ESCC cells?",{"text":117,"@type":113},"SLC1A5 stabilizes CD276 protein without changing CD276 mRNA by suppressing ROS-dependent autophagic degradation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does inhibiting glutamine metabolism influence ESCC progression?",{"text":121,"@type":113},"Inhibiting glutamine metabolism reverses CD276 overexpression–induced ESCC cell proliferation. In mice, combining the SLC1A5 inhibitor V9302 with CD276 knockout substantially reduced xenograft tumor volume without altering body weight.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354993,1790656388,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","RESEARCH ARTICLE     \nGlutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression  \nChunyan Wang, Hongyan Zhang, Chaonan Guan, Yuying Li, Shengli Yang and Lan Huang   \nTranslational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China  \nABSTRACT  \nBackground: CD276/B7-H3 is an immune checkpoint molecule often overexpressed in cancers, representing a potential therapeutic target. The underlying mechanisms for CD276 upregulation remain unclear. This study investigates how glutamine metabolism affects CD276 protein stability and esophageal squamous cell carcinoma (ESCC) progression. Methods: CD276 and SLC1A5 expression were analyzed in 90 ESCC clinical tissues and TCGA/GEO datasets. CCK-8, colony formation, wound healing and transwell assays were performed in KYSE150 and KYSE450 cells. Autophagy was quantified by immunofluorescence and western blot. Mitochondrial reactive oxygen species (ROS) levels measured by flow cytometry. Rescue experiments used N-acetylcysteine (NAC) and chloroquine (CQ) . Finally, antitumor effects of SLC1A5 inhibitor V9302 in the presence or absence of CD276 were evaluated in NOD/SCID mice (n = 5 per group) bearing KYSE150 xenografts.  \nResults: CD276 and SLC1A5 upregulated in ESCC tissues (P \u003C 0.05). CD276 overexpression enhanced ESCC cell proliferation and migration by 42.3% and 58.7%, respectively (P \u003C 0.01). CQ but not MG-132 increased CD276 expression in ESCC cells. SLC1A5 stabilized CD276 protein without altering CD276 mRNA levels, by suppressing ROS-dependent autophagic degradation. NAC reversed ROS-induced CD276 degradation, while CQ abrogated CD276 downregulation upon glutamine metabolism inhibition. Inhibiting glutamine metabolism could reverse ESCC cell proliferation induced by CD276 overexpression. Moreover, combination of V9302 and CD276 knockout significantly reduced KYSE150 cell-derived xenograft tumor volume by 65.2%(95% CI 58.3–72.1%, P \u003C 0.001) in NOD/SCID mice, without affecting mouse body weight (P > 0.05).  \nConclusion: SLC1A5 enhances CD276 stability by suppressing ROS-autophagy signaling, promoting ESCC progression. Targeting glutamine metabolism to enhance CD276 degradation might be a novel therapeutic strategy for ESCC.  \nARTICLE HISTORY  \nReceived 18 September 2025 Revised 2 January 2026 Accepted 21 January 2026  \nKEYWORDS  \nEsophageal squamous cell carcinoma; CD276;  \nglutamine metabolism; autophagy; SLC1A5  \nIntroduction  \nOesophageal cancer is a common digestive malignancy with high global incidence and mortality. 1 In China, it ranks fifth in cancer prevalence and fourth in cancer-related mortality.2 Oesophageal squamous cell carcinoma (ESCC) constitutes over 80% of cases3 and is frequently asymptomatic early on, resulting in late diagnosis and five-year survival below 20% .4 Current treatments, such as surgery, chemotherapy, and radiotherapy, have limited efficacy and notable side effects, highlighting the need for novel targets and personalised therapies.5 Although immunotherapy and targeted therapies show promise, particularly in advanced ESCC,6 elucidating the mechanisms of ESCC progression and identifying new molecular targets remain urgent priorities.  \nCD276 (B7-H3), a member of the B7 ligand family, is upregulated in multiple malignancies and closely linked to tumour growth and metastasis.7,8 CD276 modulates apoptosis to promote cell survival in cervical and gastric cancers,9, 10 confers drug resistance to impair therapeutic efficacy in colorectal and ovarian cancers, 11, 12 and drives angiogenesis to support tumour vascularisation in diverse tumours, 13-15  \nCONTACT Lan Huang  [lanhuang@zzu.edu.cn](lanhuang@zzu.edu.cn); Shengli Yang  slyang@caeshc.com.cn  Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China  \n Supplemental data for this article can be accessed online at [https://doi.org","cbCaij6yGRf9LMcP","https://ap.wps.com/l/cbCaij6yGRf9LMcP","pdf",4280040,"English","# Background\n# Methods\n## Clinical datasets and tissue analysis\n## Cell and functional assays\n## Autophagy and ROS assessment\n## Rescue and in vivo experiments\n# Results\n# Conclusion\n# Introduction\n## Esophageal cancer burden and current therapies\n## CD276 functions and knowledge gap\n## Metabolic reprogramming and glutamine-autophagy link","[{\"question\":\"What role does CD276/B7-H3 play in esophageal squamous cell carcinoma?\",\"answer\":\"CD276/B7-H3 is an immune checkpoint molecule often overexpressed in cancers. In the study, CD276 overexpression enhanced ESCC cell proliferation and migration.\"},{\"question\":\"How does SLC1A5 affect CD276 levels in ESCC cells?\",\"answer\":\"SLC1A5 stabilizes CD276 protein without changing CD276 mRNA by suppressing ROS-dependent autophagic degradation.\"},{\"question\":\"How does inhibiting glutamine metabolism influence ESCC progression?\",\"answer\":\"Inhibiting glutamine metabolism reverses CD276 overexpression–induced ESCC cell proliferation. In mice, combining the SLC1A5 inhibitor V9302 with CD276 knockout substantially reduced xenograft tumor volume without altering body weight.\"}]","Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression | PDF",1790115305,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd161935d5c3803410a2cf795e04dcd7.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f70dc0b2f36fe69921975eb79190c3e2.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5412bf23e374cea51dfc55a981f54d01.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68f80a8c3f0701dfaf5c616951430ec0.webp",980,1306]